Launxp Biomedical Co (ROCO:6876) Scaled Net Operating Assets : 0.08 (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Launxp Biomedical Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Launxp Biomedical Co's operating assets for the quarter that ended in Jun. 2024 was NT$28.17 Mil. Launxp Biomedical Co's operating liabilities for the quarter that ended in Jun. 2024 was NT$11.82 Mil. Launxp Biomedical Co's Total Assets for the quarter that ended in Dec. 2023 was NT$206.49 Mil. Therefore, Launxp Biomedical Co's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.08.

Launxp Biomedical Co Scaled Net Operating Assets Historical Data

The historical data trend for Launxp Biomedical Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Launxp Biomedical Co Scaled Net Operating Assets Chart

Launxp Biomedical Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.10

0.14

0.19

Launxp Biomedical Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial			0.13	0.13	0.80	0.06	0.08

Competitive Comparison of Launxp Biomedical Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Launxp Biomedical Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Launxp Biomedical Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Launxp Biomedical Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Launxp Biomedical Co's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Launxp Biomedical Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Launxp Biomedical Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(26.755	-	20.545)	/	32.443
=	0.19

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	206.489	-	179.734
=	26.755

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	23.193	-	1.701	-	0.947
=	20.545

Launxp Biomedical Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(28.169	-	11.824)	/	206.489
=	0.08

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	161.885	-	133.716
=	28.169

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	13.997	-	1.226	-	0.947
=	11.824

Launxp Biomedical Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Launxp Biomedical Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Launxp Biomedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Launxp Biomedical Co Ltd (ROCO:6876) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

10F, No. 51, Section 2, Gongyi Road, Nantun District, Taichung, TWN, 408

Website

https://www.launxp.com

Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.

Launxp Biomedical Co Headlines

No Headlines